The expression of bullous pemphigoid (BP) antigen in different locations on the body was estimated from the highest dilution of BP sera giving a positive reaction at a site by indirect immunofluoresconce. Three sera with high titers (640–1280) of BP antibodies against monkey and guinea pig esophagus were reacted with 46 specimens of normal human skin. There was marked variation in the expression of BP antigen in skin obtained from different sites. The greatest expression of BP antigen was in skin obtained from the flexor surfaces of the arm, leg, and thigh. All specimens from these sites reacted with high dilutions (1:640–1:2560) of BP antibodies. BP antigen was expressed least in skin specimens from scalp, face, and extensor surface of the...
Bullous pemphigoid is a subepidermal bullous disease of skin and mucosae associated with autoantibod...
Several components of the dermal – epidermal junction (DBJ) bear the name of the autoimmune bullous ...
We studied sera from 59 patients with bullous pemphigoid (BP) and 25 control subjects (normal volunt...
The immunologic specificity of bullous pemphigoid (BP) antigens expressed in human skin was studied ...
The major bullous pemphigoid (BP) antigen is a 220-240-kDa polypeptide, although some BP sera recogn...
Indirect immunofluorescence was performed on skin from 13 patients with epidermolysis bullosa (EB) (...
The expression of the pemphigus foliaceus (PF), pemphigus erythematosus (PE), and pemphigus vulgaris...
Two bullous pemphigoid antigens (BPAs) have been identified: a 230-kD intracellular hemidesmosome-as...
There are a number of controversies relating to studies of bullous pemphigold (BP) antigens from dif...
Bullous pemphigoid is characterized by the presence of both circulating and tissue-fixed antibasemen...
The immunoelectron microscopic reaction products showing in vivo bound immunoglobulins or complement...
The bullous pemphigoid antigen was originally described as a 240-kD protein extracted from human epi...
In early studies, the bullous pemphigoid antigen (BPA) has been localized extracellularly in the lam...
Bullous pemphigoid was first described by Lever in 1953 as a subepidermal blistering disease. Its im...
Eight out of 12 serum samples from patients with bullous pemphigoid having basement membrane zone an...
Bullous pemphigoid is a subepidermal bullous disease of skin and mucosae associated with autoantibod...
Several components of the dermal – epidermal junction (DBJ) bear the name of the autoimmune bullous ...
We studied sera from 59 patients with bullous pemphigoid (BP) and 25 control subjects (normal volunt...
The immunologic specificity of bullous pemphigoid (BP) antigens expressed in human skin was studied ...
The major bullous pemphigoid (BP) antigen is a 220-240-kDa polypeptide, although some BP sera recogn...
Indirect immunofluorescence was performed on skin from 13 patients with epidermolysis bullosa (EB) (...
The expression of the pemphigus foliaceus (PF), pemphigus erythematosus (PE), and pemphigus vulgaris...
Two bullous pemphigoid antigens (BPAs) have been identified: a 230-kD intracellular hemidesmosome-as...
There are a number of controversies relating to studies of bullous pemphigold (BP) antigens from dif...
Bullous pemphigoid is characterized by the presence of both circulating and tissue-fixed antibasemen...
The immunoelectron microscopic reaction products showing in vivo bound immunoglobulins or complement...
The bullous pemphigoid antigen was originally described as a 240-kD protein extracted from human epi...
In early studies, the bullous pemphigoid antigen (BPA) has been localized extracellularly in the lam...
Bullous pemphigoid was first described by Lever in 1953 as a subepidermal blistering disease. Its im...
Eight out of 12 serum samples from patients with bullous pemphigoid having basement membrane zone an...
Bullous pemphigoid is a subepidermal bullous disease of skin and mucosae associated with autoantibod...
Several components of the dermal – epidermal junction (DBJ) bear the name of the autoimmune bullous ...
We studied sera from 59 patients with bullous pemphigoid (BP) and 25 control subjects (normal volunt...